ITIH4 and neoplasm: Two IgMs with two distinct antigen specificities were produced: HB617, which targets the membrane glycosphingolipid of tumor cells GM3/GD3, and 2G12, which targets mannosic chains of the envelop protein of the human immunodeficiency virus (HIV) gp120 [29,30,31,32].